NYSE:LCI Lannett (LCI) Stock Price, News & Analysis → AI healthcare stock poised for 36,996% growth? (From Behind the Markets) (Ad) Free LCI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.65▼$2.5152-Week Range N/AVolume280,600 shsAverage Volume92,067 shsMarket Capitalization$7.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Lannett alerts: Email Address Ad Behind the MarketsAI healthcare stock poised for 36,996% growth?Buy Alert Issued For AI Small Cap Our last two AI stocks jumped 150% and 130%... But we just issued a brand new "buy alert" for a new one...Get the name of the stock here... About Lannett Stock (NYSE:LCI)Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.Read More Ad Behind the MarketsAI healthcare stock poised for 36,996% growth?Buy Alert Issued For AI Small Cap Our last two AI stocks jumped 150% and 130%... But we just issued a brand new "buy alert" for a new one...Get the name of the stock here... LCI Stock News HeadlinesSeptember 20, 2023 | wsj.comLucky Core Industries Ltd.September 15, 2023 | thestreet.comLannett (LCI) Stock Sinks on Lowered Guidance, Canaccord DowngradeMarch 28, 2024 | Behind the Markets (Ad)AI healthcare stock poised for 36,996% growth?Buy Alert Issued For AI Small Cap Our last two AI stocks jumped 150% and 130%... But we just issued a brand new "buy alert" for a new one...May 1, 2023 | finance.yahoo.comLannett Company, Inc. Enters Into Restructuring Support AgreementApril 20, 2023 | finance.yahoo.comNYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGSApril 4, 2023 | finance.yahoo.comLANNETT SHARES UPDATEFebruary 26, 2023 | thestreet.comWhy Lannett (LCI) Stock Is Down TodayFebruary 7, 2023 | finance.yahoo.comRecent uptick might appease Lannett Company, Inc. (NYSE:LCI) institutional owners after losing 26% over the past yearMarch 28, 2024 | Behind the Markets (Ad)AI healthcare stock poised for 36,996% growth?Buy Alert Issued For AI Small Cap Our last two AI stocks jumped 150% and 130%... But we just issued a brand new "buy alert" for a new one...February 2, 2023 | finance.yahoo.comLannett Company, Inc. (NYSE:LCI) Q2 2023 Earnings Call TranscriptFebruary 1, 2023 | finance.yahoo.comLANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCEFebruary 1, 2023 | finance.yahoo.comLannett (LCI) Reports Q2 Loss, Tops Revenue EstimatesJanuary 25, 2023 | finance.yahoo.comLANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLITJanuary 25, 2023 | finance.yahoo.comLANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1January 4, 2023 | finance.yahoo.comLANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTSNovember 9, 2022 | finance.yahoo.comLannett Company First Quarter 2023 Earnings: Revenues Beat Expectations, EPS LagsNovember 7, 2022 | finance.yahoo.comLANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAMNovember 2, 2022 | finance.yahoo.comLANNETT REPORTS BETTER THAN EXPECTED FINANCIAL RESULTS FOR FISCAL 2023 FIRST-QUARTER; REITERATES FULL-YEAR GUIDANCEOctober 26, 2022 | finance.yahoo.comLANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2October 21, 2022 | finance.yahoo.comLANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO® AT SEYMOUR PLANTOctober 19, 2022 | prnewswire.comLANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGS - PR NewswireOctober 19, 2022 | finance.yahoo.comLANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGSOctober 15, 2022 | seekingalpha.comLCI Lannett Company, Inc.October 5, 2022 | finance.yahoo.comLannett Company, Inc. (LCI)September 28, 2022 | law360.comEx-Pharma CEO Denied 3rd Circ. Rehearing In $1M FBAR Case - Law360September 26, 2022 | forbes.comProbability Of Default Is Rising For High Yield Bonds And Leveraged Loans - ForbesSeptember 19, 2022 | bloomberg.comAdderall Shortages in US Spread to Two More Drug Suppliers - BloombergSee More Headlines Receive LCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/03/2021Today3/28/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolNYSE:LCI CUSIP51601210 CIK57725 Webwww.lannett.com Phone(215) 333-9000Fax215-333-9004Employees810Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($18.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-231,620,000.00 Net Margins-62.40% Pretax Margin-62.67% Return on EquityN/A Return on Assets-13.39% Debt Debt-to-Equity RatioN/A Current Ratio2.23 Quick Ratio1.39 Sales & Book Value Annual Sales$340.58 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($23.34) per share Price / BookN/AMiscellaneous Outstanding Shares10,770,000Free Float9,354,000Market Cap$7.38 million OptionableOptionable Beta0.95 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesTimothy C. CrewChief Executive Officer & DirectorJohn KozlowskiChief Financial Officer & Vice President-FinanceRobert EhlingerChief Information Officer & Vice PresidentMaureen M. CavanaughChief Commercial Operations Officer & Senior VPJohn M. AbtChief Quality Operations Officer & Vice PresidentKey CompetitorsCumberland PharmaceuticalsNASDAQ:CPIXAinosNASDAQ:AIMDHillstream BioPharmaNASDAQ:HILSPasithea TherapeuticsNASDAQ:KTTAShuttle PharmaceuticalsNASDAQ:SHPHView All Competitors LCI Stock Analysis - Frequently Asked Questions How were Lannett's earnings last quarter? Lannett Company, Inc. (NYSE:LCI) issued its quarterly earnings data on Wednesday, November, 3rd. The company reported ($1.08) EPS for the quarter, missing the consensus estimate of ($1.00) by $0.08. The business earned $101.53 million during the quarter, compared to the consensus estimate of $98.62 million. During the same quarter in the prior year, the firm posted $0.24 earnings per share. When did Lannett's stock split? Shares of Lannett reverse split on Tuesday, February 7th 2023. The 1-4 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. What is Timothy Crew's approval rating as Lannett's CEO? 9 employees have rated Lannett Chief Executive Officer Timothy Crew on Glassdoor.com. Timothy Crew has an approval rating of 28% among the company's employees. This puts Timothy Crew in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Lannett own? Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include Akorn (AKRX), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA). This page (NYSE:LCI) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingInvestors Alert: The Next Big Thing in Weight LossBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lannett Company, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.